Healthcare -
Biotechnology - NASDAQ - US
$ 6.74
2.43 %
$ 686 M
Market Cap
-14.98
P/E
TRVI - FREE CASH FLOW
Free Cash Flow TRVI - Trevi Therapeutics, Inc.
-38.3 M
LAST VALUE
-16.25%
2 YEAR CAGR
-10.63%
5 YEAR CAGR
0.00%
10 YEAR CAGR